Literature DB >> 35218423

Investigation of interactions of doxorubicin with purine nucleobases by molecular modeling.

Esra Şahin Akdeniz1,2, Cenk Selçuki3,4.   

Abstract

Doxorubicin, an anthracycline antibiotic with anti-tumor activity, is produced by the bacterium Streptomyces peucetius. The interactions between doxorubicin and genetic material and the details of the intercalation with DNA have been controversial issues. Thus, the interactions of doxorubicin with purine nucleobases were studied by quantum mechanical methods. Initially, conformer analyses of doxorubicin were performed with Spartan 08 software and 319 different conformers from 422 initial structures for doxorubicin were obtained. Geometry optimizations and frequency analyses were performed for each structure using density functional theory (DFT) at B3LYP/6-31G** level using Gaussian 09 software. The most stable 20 conformers of doxorubicin and tautomers of purine nucleobases were optimized again with ɷB97XD/6-31G** level and their interactions were also analyzed at the same level. The Discovery Studio 3.5 Visualizer was used to draw the initial and optimized structures of investigated geometries. The noncovalent interactions (NCIs) were visualized by calculating reduced density gradient (RDG) with Multiwfn program. The color-filled isosurfaces and RDG scatter maps of most stable interaction geometries were plotted by Visual Molecular Dynamics (VMD) software and Gnuplot 5.3 software, respectively. This study showed that adenine, guanine, and hypoxanthine nucleobases interact with doxorubicin by forming strong hydrogen bonds and π-π interactions. Considering the normal cellular conditions, the effect of solvent (water) on the interaction geometries were also analyzed and when compared to gas phase it was determined that the movements of the molecules were restricted and there was a minimal change between initial and optimized structures in the aqueous phase.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Density functional theory; Doxorubicin; Molecular modeling; Purine nucleobases

Mesh:

Substances:

Year:  2022        PMID: 35218423     DOI: 10.1007/s00894-022-05031-z

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  27 in total

1.  Two hundred years of cancer research.

Authors:  Vincent T DeVita; Steven A Rosenberg
Journal:  N Engl J Med       Date:  2012-05-30       Impact factor: 91.245

2.  Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid.

Authors:  S FARBER; L K DIAMOND
Journal:  N Engl J Med       Date:  1948-06-03       Impact factor: 91.245

3.  Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: structural features and biological implications.

Authors:  Daniel Agudelo; Philippe Bourassa; Gervais Bérubé; Heidar-Ali Tajmir-Riahi
Journal:  Int J Biol Macromol       Date:  2014-02-20       Impact factor: 6.953

4.  Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase pi.

Authors:  S Goto; Y Ihara; Y Urata; S Izumi; K Abe; T Koji; T Kondo
Journal:  FASEB J       Date:  2001-12       Impact factor: 5.191

5.  Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.

Authors:  Ping Ma; Russell J Mumper
Journal:  Nano Today       Date:  2013-06-01       Impact factor: 20.722

Review 6.  A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.

Authors:  D A Gewirtz
Journal:  Biochem Pharmacol       Date:  1999-04-01       Impact factor: 5.858

7.  Nanopore single-molecule analysis of DNA-doxorubicin interactions.

Authors:  Fujun Yao; Jing Duan; Ying Wang; Yue Zhang; Yanli Guo; Huilin Guo; Xiaofeng Kang
Journal:  Anal Chem       Date:  2014-12-15       Impact factor: 6.986

Review 8.  Review on the binding of anticancer drug doxorubicin with DNA and tRNA: Structural models and antitumor activity.

Authors:  D Agudelo; P Bourassa; G Bérubé; H A Tajmir-Riahi
Journal:  J Photochem Photobiol B       Date:  2016-03-04       Impact factor: 6.252

9.  Clinical evaluation of adriamycin, a new antitumour antibiotic.

Authors:  G Bonadonna; S Monfardini; M De Lena; F Fossati-Bellani
Journal:  Br Med J       Date:  1969-08-30

Review 10.  Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.

Authors:  Giorgio Minotti; Pierantonio Menna; Emanuela Salvatorelli; Gaetano Cairo; Luca Gianni
Journal:  Pharmacol Rev       Date:  2004-06       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.